Indoco Remedies gets USFDA nod to market generic diabetes drug

Indoco Remedies on Thursday said it has received approval from the US health regulator to market a generic diabetes medication. The company has received tentative approval from the US Food and Drug Administration (USFDA) for abbreviated new drug application (ANDA) for Canagliflozin and Metformin Hydrochloride tablets in various strengths, Indoco Remedies said in a regulatory filing.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/wHbSIzu
via IFTTT